Evidence map›Paper›PMID 29142889›Full record

ArticleAdvanced biomedical research2017

Rapid Detection of Streptomycin-Resistant

Sediqe Karimi, Hossein Mirhendi, Fatemh Riyahi Zaniani, Soroor Erfani Manesh, Mahshd Salehi, Bahram Nasr Esfahani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced biomedical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. An updated systematic review and meta-analysis onIranian journal of basic medical sciences · 2021
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sediqe KarimiDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Hossein MirhendiDepartment of Medical Parasitology and Mycology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Fatemh Riyahi ZanianiDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Soroor Erfani ManeshDepartment of Microbiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mahshd SalehiMollahadi Sabzevari Tuberculosis Center, Isfahan, Iran.
Bahram Nasr EsfahaniDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMolecular methods for the detection of drug-resistant tuberculosis (DR-TB) are potentially more rapid than conventional culture-based drug susceptibility testing, facilitating the commencement of appropriate treatment for patients with DR-TB. The aim of this study was to evaluate and develop polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assays for the detection of mutations within MATERIALS AND

methodsClinical specimens were collected from individuals with suspected TB referred to the TB Center of Isfahan, from which 205

resultsThree (30%) isolates showed point mutation at codon 43 by RLFP analysis.

conclusionOur results suggest that RFLP analysis of the

Indexed as

Mycobacterium tuberculosisresistancerestriction fragment length polymorphismrpsL genestreptomycin

Identifiers

PMID29142889
PMCPMC5672647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.